Celsius Holdings, Inc. (NASDAQ:CELH – Get Free Report)’s stock price traded down 4.6% on Wednesday after Morgan Stanley lowered their price target on the stock from $46.00 to $42.00. Morgan Stanley currently has an equal weight rating on the stock. Celsius traded as low as $27.85 and last traded at $27.89. 3,643,571 shares traded hands during mid-day trading, a decline of 41% from the average session volume of 6,190,117 shares. The stock had previously closed at $29.24.
A number of other equities research analysts have also recently issued reports on CELH. UBS Group cut their price objective on shares of Celsius from $50.00 to $45.00 and set a “buy” rating for the company in a research note on Thursday, November 7th. Deutsche Bank Aktiengesellschaft began coverage on shares of Celsius in a research note on Thursday, December 12th. They issued a “hold” rating and a $32.00 price target for the company. Needham & Company LLC assumed coverage on Celsius in a research note on Friday, December 6th. They set a “buy” rating and a $38.00 price objective on the stock. LADENBURG THALM/SH SH lowered their target price on Celsius from $72.00 to $68.00 and set a “neutral” rating for the company in a research note on Monday, October 21st. Finally, B. Riley reduced their price target on Celsius from $50.00 to $47.00 and set a “buy” rating on the stock in a research report on Monday, November 4th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat, Celsius presently has an average rating of “Moderate Buy” and an average price target of $50.72.
View Our Latest Analysis on CELH
Insider Activity
Hedge Funds Weigh In On Celsius
Institutional investors have recently added to or reduced their stakes in the company. Charles Schwab Investment Management Inc. boosted its holdings in shares of Celsius by 19.1% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,381,279 shares of the company’s stock valued at $43,317,000 after buying an additional 221,833 shares in the last quarter. Van ECK Associates Corp boosted its stake in Celsius by 169.8% during the third quarter. Van ECK Associates Corp now owns 29,324 shares of the company’s stock worth $893,000 after acquiring an additional 18,456 shares in the last quarter. Savoir Faire Capital Management L.P. boosted its stake in Celsius by 17.1% during the third quarter. Savoir Faire Capital Management L.P. now owns 173,518 shares of the company’s stock worth $5,442,000 after acquiring an additional 25,315 shares in the last quarter. Vontobel Holding Ltd. increased its stake in shares of Celsius by 93.5% during the third quarter. Vontobel Holding Ltd. now owns 47,147 shares of the company’s stock valued at $1,479,000 after purchasing an additional 22,786 shares in the last quarter. Finally, iA Global Asset Management Inc. purchased a new position in shares of Celsius during the third quarter valued at approximately $2,772,000. Institutional investors own 60.95% of the company’s stock.
Celsius Stock Performance
The stock has a market capitalization of $6.37 billion, a P/E ratio of 37.63, a PEG ratio of 3.44 and a beta of 1.76. The business has a 50-day moving average price of $30.03 and a 200 day moving average price of $40.38.
Celsius Company Profile
Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.
Featured Stories
- Five stocks we like better than Celsius
- What Makes a Stock a Good Dividend Stock?
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- Using the MarketBeat Dividend Yield Calculator
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- The Significance of Brokerage Rankings in Stock Selection
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for Celsius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celsius and related companies with MarketBeat.com's FREE daily email newsletter.